Patents Assigned to Merck Patents GmbH
  • Patent number: 9978944
    Abstract: The present invention relates to organic electronic devices, and more specifically to organic field effect transistors, comprising a dielectric layer that comprises a polycycloolefinic polymer with an olefinic side chain.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: May 22, 2018
    Assignees: PROMERUS, LLC, MERCK PATENT GMBH
    Inventors: Larry F Rhodes, Crystal D Cyrus, Hugh A Burgoon, Irina Afonina, Toby Cull
  • Patent number: 9978950
    Abstract: The present application relates to a compound of a formula (I) which contains a spirobifluorene basic structure condensed onto a benzofuran unit. The application furthermore relates to a process for the preparation of the compound of the formula (I), and to the use of the compound of the formula (I) in an electronic device.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: May 22, 2018
    Assignee: Merck Patent GmbH
    Inventors: Jochen Pfister, Frank Voges, Elvira Montenegro, Teresa Mujica-Fernaud
  • Patent number: 9978949
    Abstract: The application relates to a compound of a formula (I) which is suitable for use as functional material in electronic devices.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: May 22, 2018
    Assignee: Merck Patent GmbH
    Inventors: Teresa Mujica-Fernaud, Elvira Montenegro, Frank Voges, Jonas Valentin Kroeber, Philipp Stoessel
  • Patent number: 9978957
    Abstract: Triphenylene derivatives, in particular for use as triplet matrix materials in organic electroluminescent devices, one of example of which is represented by formula I. The invention furthermore relates to a process for the preparation of the triphenylene derivatives and to electronic devices comprising the triphenylene derivatives.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: May 22, 2018
    Assignee: Merck Patent GmbH
    Inventors: Anja Jatsch, Rémi M. Anémian, Bernd Schröder, Arne Buesing, Philipp Stoessel, Christof Pflumm, Jonas V. Kroeber, Thomas Eberle
  • Patent number: 9975932
    Abstract: The present invention relates to the preparation and use of recombinant variants of group 5 allergens of the Poaceae (true grasses), which are characterized by reduced IgE reactivity compared with known wild-type allergens and at the same time substantially retained reactivity with T-lymphocytes.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: May 22, 2018
    Assignee: Merck Patent GmbH
    Inventors: Martin Wald, Andreas Nandy, Helmut Fiebig, Bernhard Weber, Helga Kahlert, Gerald Reese, Oliver Cromwell
  • Patent number: 9976999
    Abstract: A method for performing thin-layer chromatography applies a liquid sample to a separating layer. A mobile phase is subsequently applied to the separating layer and brought into contact with the liquid sample. After a developmental phase, a thin-layer chromatogram is produced. The liquid sample is taken up from a sample storage container with the aid of an autopipette using a new pipette tip for each sample application operation and applied to the separating layer. A device for performing the method includes a support plate for the accommodation of the separating layer, a first storage container for the accommodation of the sample, and a second storage container for the accommodation of the mobile phase.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: May 22, 2018
    Assignee: MERCK PATENT GMBH
    Inventor: Michael Schulz
  • Patent number: 9977309
    Abstract: This invention relates to electrophoretic fluids comprising a solvent, a dye, white particles, and colored particles selected from red, green, blue, magenta, cyan, yellow particles, and mixtures thereof, and electrophoretic display devices comprising such fluids.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: May 22, 2018
    Assignee: Merck Patent GmbH
    Inventor: Nathan Smith
  • Publication number: 20180134960
    Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1 and R1* each, independently of one another, denote an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, A1 denotes L1 denotes F, Cl, CF3, OCF3 or CHF2, and to the use thereof for electro-optical purposes, in particular for shutter glasses, 3D applications, in TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, PS-FFS and PS-VA-IPS displays.
    Type: Application
    Filed: April 8, 2016
    Publication date: May 17, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Helmut HAENSEL, Andreas POHLE, Brigitte SCHULER, Christian JASPER
  • Publication number: 20180134959
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising a polymerisable compound, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in an LC display of the polymer sustained alignment (PSA) type, and to an LC display, especially a PSA display, comprising it.
    Type: Application
    Filed: April 29, 2016
    Publication date: May 17, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Eun-Kyu LEE, Jin-Soon PARK, Hyun-Jin YOON, Min-OK JIN, Yong-Kuk YUN
  • Publication number: 20180133334
    Abstract: The present invention is directed to carrier systems comprising ether-lipids conjugated to one or more bioactive ligands and exposed on the surface of the carrier system for use in targeted delivery and/or antigen display systems. Optionally one or more further bioactive agents may be encapsulated or embedded within or attached to or adsorbed onto the carrier system. The present invention is further directed to methods of their preparation and their uses in medical applications, such as targeted delivery of bioactive agents to specific tissues or cells and antigen display systems for the study, diagnosis, and treatment of traits, diseases and conditions that respond to said bioactive agents.
    Type: Application
    Filed: January 11, 2018
    Publication date: May 17, 2018
    Applicant: Merck Patent GmbH
    Inventors: Michael PLATSCHER, Raymond BEHRENDT, Viola GROEHN, Simone HOERTNER, Marco PASSAFARO, Finn BAUER
  • Patent number: 9972782
    Abstract: The invention relates to formulations containing doped conductive polymers, which due to outstanding hole injection characteristics and high conductivity are very suitable for use in organic electronic devices, preferably in organic electroluminescent devices, in particular in the buffer layers thereof. Thus the invention further relates to the use of the formulations according to the invention in organic electronic devices, preferably in electroluminescent devices, in particular in the buffer layers thereof.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: May 15, 2018
    Assignee: Merck Patent GmbH
    Inventors: Heinrich Becker, Susanne Heun
  • Patent number: 9969710
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: May 15, 2018
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-Lebrun, Ruoxi Lan, Austin Chen, Ryan C. Clark
  • Publication number: 20180126298
    Abstract: The invention relates to a device for substance separation with monolithic sorbents which can be produced by means of 3-D printing. They comprise pressure- and solvent-stable thermoplastics.
    Type: Application
    Filed: May 2, 2016
    Publication date: May 10, 2018
    Applicant: Merck Patent GmbH
    Inventors: Karin CABRERA, Klaus KREHER, Gisela JUNG
  • Patent number: 9963637
    Abstract: The present invention relates to a liquid crystalline medium comprising a polymerizable compound, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in liquid crystalline displays, especially in a liquid crystalline display of the polymer sustained alignment (PSA) type, and to a liquid crystalline display, especially a PSA display, comprising it.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: May 8, 2018
    Assignee: Merck Patent GmbH
    Inventors: Eun-Kyu Lee, Hyun-Jin Yoon, Ji-Won Jeong, Hye-Ryung Park, Seung-Jai Kim, Yong-Jun Ji, Min-Ok Jin, Yong-Kuk Yun
  • Publication number: 20180119010
    Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, rings A and B, Z1, L1, L2, a and b have the meanings indicated in Claim 1, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS, PS-FFS, IPS or PS-IPS effect.
    Type: Application
    Filed: December 29, 2017
    Publication date: May 3, 2018
    Applicant: Merck Patent GmbH
    Inventors: Melanie KLASEN-MEMMER, Achim GOETZ, Georg BERNATZ
  • Publication number: 20180122974
    Abstract: The invention relates to a polymer film comprising an inorganic fluorescent compound and an organic fluorescent compound. The invention further relates methods for preparing such a film, and to its use as wavelength conversion film in a solar cell.
    Type: Application
    Filed: December 18, 2017
    Publication date: May 3, 2018
    Applicant: Merck Patent GmbH
    Inventors: Hiroshi OKURA, Takeo WAKIMOTO, Katsuyuki MATSUI, Noriyuki MATSUDA, Masayoshi SUZUKI, Tadashi KISHIMOTO
  • Publication number: 20180118721
    Abstract: Compounds of Formula I or II in which R1, X1 and X2 have the meanings indicated in claim 1, are MTH1 inhibitors and can be employed, inter alia, in the treatment of cancer.
    Type: Application
    Filed: February 12, 2016
    Publication date: May 3, 2018
    Applicant: Merck Patent GmbH
    Inventors: Timo HEINRICH, Ulrich PEHL
  • Publication number: 20180122640
    Abstract: The present invention relates to a novel printable boron doping paste in the form of a hybrid gel based on precursors of inorganic oxides, preferably of silicon dioxide, aluminium oxide and boron oxide, in the presence of organic polymer particles, where the pastes according to the invention can be used in a simplified process for the production of solar cells, where the hybrid gel according to the invention functions both as doping medium and as diffusion barrier.
    Type: Application
    Filed: March 24, 2016
    Publication date: May 3, 2018
    Applicant: MERCK PATENT GMBH
    Inventors: Oliver DOLL, Ingo KOEHLER, Sebastian BARTH
  • Patent number: 9956813
    Abstract: A dispenser for opening a tape like packaging comprising first and second films releasably connected to each other, forming envelopes sealed around an object, and disposed sequentially with a predetermined pitch. The dispenser comprises a space for holding a container of the packaging, a separator through which the packaging can be passed, for spreading apart and separating the films at an outlet thereof when a pulling force is acting on said first and second films, thereby opening envelopes and releasing the objects contained therein, and means for winding up separated first and second films of the tape like packaging. The separator further comprises a cover member that is articulated to the dispenser to be movable between a closed position and an open position.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: May 1, 2018
    Assignee: Merck Patent GmbH
    Inventors: Gerard Muller, Mathieu Arrault, Jean-Jacques Richert
  • Patent number: 9951274
    Abstract: The invention relates to compounds of the formula I, to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, L1, L2, L3 and L4 have the meanings indicated herein, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PM-VA, PALC, IPS, PS-IPS, SA-VA, SS-VA, FFS or PS-FFS effect.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: April 24, 2018
    Assignee: MERCK PATENT GMBH
    Inventors: Harald Hirschmann, Monika Bauer, Martina Windhorst, Marcus Reuter, Volker Reiffenrath, Matthias Bremer